Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AVIR US Equity

Atea Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1593899 · FY ends Dec 31
$5.59
+0.31 (+5.87%)
USD · as of 2026-08-19 · marketstack
6 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-228-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-0913GSchedule 13G filed — ≥5% beneficial owner (passive) · by BML Investment Partners, L.P.sec.gov ↗
2026-01-088-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-12-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-11-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-12

Every row is a filed document, checked against its EDGAR index.